Written by
Ted Samson
If hot flashes or night sweats are disrupting your sleep or daily routine, new medical guidance may help you explore treatment options.
The American College of Physicians (ACP) has released a new guideline recommending hormone therapy as the first-choice medication treatment for people who are appropriate candidates. The guideline also identifies nonhormonal treatments for those who cannot take hormones or have trouble tolerating them.
The recommendations could help those experiencing menopause have more informed conversations with their healthcare providers about managing symptoms.
Hot flashes and night sweats are among the most common symptoms of menopause, affecting up to 80 percent of those going through this transition.
Hot flashes cause sudden feelings of warmth, often accompanied by sweating. When they occur during sleep, they’re known as night sweats.
These symptoms are also called vasomotor symptoms. They can begin during perimenopause, the years leading up to menopause, as reproductive hormone levels change.
For some, hot flashes are occasional and manageable. For others, they can interfere with sleep, work, and everyday activities. Symptoms may also continue for years after menopause.
Learn how other members of ThisIsMenopause control hot flashes. ❯
The ACP reviewed available evidence on medications used to manage hot flashes and night sweats. Its recommendations identify treatments according to how their benefits compare with potential harms.
Hormone therapy replaces some of the estrogen that declines during menopause. According to the ACP, estrogen-based treatments offer the most favorable balance of benefits and risks for eligible people seeking relief from hot flashes.
The recommended approach depends on whether someone has a uterus:
However, hormone therapy isn’t appropriate for everyone. People with certain medical histories, including breast cancer, blood clots, or some cardiovascular conditions, may face greater risks. A healthcare provider can help assess your individual circumstances.
The new guideline also identifies several nonhormonal medications that may help reduce hot flashes and night sweats.
For people who cannot take estrogen or don’t tolerate it, the ACP suggests the following alternatives.
The guideline recommends considering serotonin-norepinephrine reuptake inhibitors (SNRIs), specifically venlafaxine and desvenlafaxine.
Although these medications were developed to treat depression and other conditions, they can also help manage menopausal hot flashes.
The ACP identifies several other options:
Both fezolinetant and elinzanetant have received U.S. Food and Drug Administration (FDA) approval for moderate to severe menopausal hot flashes.
Importantly, being listed as a third-line option doesn’t mean a treatment won’t work. The rankings reflect the ACP’s assessment of the available evidence, benefits, and potential harms.
The new guideline offers a clearer road map for managing hot flashes and night sweats. It identifies hormone therapy as the preferred medication treatment for those who can safely take it, while highlighting nonhormonal alternatives.
Importantly, not everyone experiencing menopause needs medication. Those with mild or manageable symptoms may prefer to go without prescription treatment. For those whose symptoms interfere with sleep, work, or daily activities, however, the guideline provides a starting point for exploring treatments that may improve quality of life.
If hot flashes or night sweats are affecting you, consider talking with your healthcare provider about how different treatments might fit your needs and preferences. Tracking how often symptoms occur and how they affect your daily life can help make that conversation more productive.
Become a member to get even more
Join the conversation
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.